These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 7527643)

  • 1. Propagation of large numbers of T cells with natural killer cell markers.
    Schmidt-Wolf IG; Lefterova P; Johnston V; Huhn D; Blume KG; Negrin RS
    Br J Haematol; 1994 Jul; 87(3):453-8. PubMed ID: 7527643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of large and small CD3- CD56+ lymphocytes mediating NK-associated activities.
    Ortaldo JR; Winkler-Pickett R; Kopp W; Kawasaki A; Nagashima K; Okumura K; Yagita H; Bach FH
    J Leukoc Biol; 1992 Sep; 52(3):287-95. PubMed ID: 1381742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propagation of large numbers of cells of a human mixed-lineage T-lymphoid/myeloid.
    Schmidt-Wolf IG; Grimm B; Lefterova P; Johnston V; Scheffold C; Huhn D; Serke S
    Br J Haematol; 1995 Jul; 90(3):512-7. PubMed ID: 7646987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of Fc gamma receptor IIIA and interleukin-2 receptor beta chain by a subset of human CD3+/CD8+/CD11b+ lymphocytes.
    Zupo S; Azzoni L; Massara R; D'Amato A; Perussia B; Ferrarini M
    J Clin Immunol; 1993 May; 13(3):228-36. PubMed ID: 7686565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
    Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
    Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies of CD3- and CD3+ CD56+ cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression.
    Ortaldo JR; Winkler-Pickett RT; Yagita H; Young HA
    Cell Immunol; 1991 Sep; 136(2):486-95. PubMed ID: 1714795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fc gamma RIII activation is different in CD16+ cytotoxic T lymphocytes and natural killer cells.
    Uciechowski P; Gessner JE; Schindler R; Schmidt RE
    Eur J Immunol; 1992 Jun; 22(6):1635-8. PubMed ID: 1376268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of MHC-unrestricted cytotoxic activity of human CD56+ CD3- natural killer (NK) cells and CD3+ T cells by rhamnogalacturonan: target cell specificity and activity against NK-insensitive targets.
    Zhu HG; Zollner TM; Klein-Franke A; Anderer FA
    J Cancer Res Clin Oncol; 1994; 120(7):383-8. PubMed ID: 7514604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe chronic autoimmune thrombocytopenic purpura is associated with an expansion of CD56+ CD3- natural killer cells subset.
    Garcia-Suarez J; Prieto A; Reyes E; Manzano L; Merino JL; Alvarez-Mon M
    Blood; 1993 Sep; 82(5):1538-45. PubMed ID: 7689873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel CD56- lymphokine-activated killer cell precursor in cancer patients receiving recombinant interleukin 2.
    McKenzie RS; Simms PE; Helfrich BA; Fisher RI; Ellis TM
    Cancer Res; 1992 Nov; 52(22):6318-22. PubMed ID: 1384959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.
    Moretta A; Poggi A; Pende D; Tripodi G; Orengo AM; Pella N; Augugliaro R; Bottino C; Ciccone E; Moretta L
    J Exp Med; 1991 Dec; 174(6):1393-8. PubMed ID: 1720808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct granzyme expression in human CD3- CD56+ large granular- and CD3- CD56+ small high density-lymphocytes displaying non-MHC-restricted cytolytic activity.
    Smyth MJ; Browne KA; Kinnear BF; Trapani JA; Warren HS
    J Leukoc Biol; 1995 Jan; 57(1):88-93. PubMed ID: 7530284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term cultures of human peripheral blood lymphocytes with recombinant human interleukin-2 generate a population of virtually pure CD3+ CD16- CD56- large granular lymphocyte LAK cells.
    Roussel E; Gerrard JM; Greenberg AH
    Clin Exp Immunol; 1990 Nov; 82(2):416-21. PubMed ID: 1700746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon,delta proteins.
    Phillips JH; Hori T; Nagler A; Bhat N; Spits H; Lanier LL
    J Exp Med; 1992 Apr; 175(4):1055-66. PubMed ID: 1372642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoid subsets in acute myeloid leukemias: increased number of cells with NK phenotype and normal T-cell distribution.
    Vidriales MB; Orfao A; López-Berges MC; González M; Hernandez JM; Ciudad J; López A; Moro MJ; Martínez M; San Miguel JF
    Ann Hematol; 1993 Nov; 67(5):217-22. PubMed ID: 7694663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new method for in vitro expansion of cytotoxic human CD3-CD56+ natural killer cells.
    Carlens S; Gilljam M; Chambers BJ; Aschan J; Guven H; Ljunggren HG; Christensson B; Dilber MS
    Hum Immunol; 2001 Oct; 62(10):1092-8. PubMed ID: 11600215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12.
    Bennett IM; Zatsepina O; Zamai L; Azzoni L; Mikheeva T; Perussia B
    J Exp Med; 1996 Nov; 184(5):1845-56. PubMed ID: 8920872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10.
    Goodier MR; Londei M
    J Immunol; 2000 Jul; 165(1):139-47. PubMed ID: 10861046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes.
    Franceschetti M; Pievani A; Borleri G; Vago L; Fleischhauer K; Golay J; Introna M
    Exp Hematol; 2009 May; 37(5):616-628.e2. PubMed ID: 19375652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.
    Moretta A; Bottino C; Pende D; Tripodi G; Tambussi G; Viale O; Orengo A; Barbaresi M; Merli A; Ciccone E
    J Exp Med; 1990 Dec; 172(6):1589-98. PubMed ID: 2147946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.